What are the major opportunities in the Lewy Body Dementia market? What are the strategies for the Lewy Body Dementia market?

For detailed insights on the major opportunities and strategies in the Lewy Body Dementia market, Read More

How does the Lewy Body Dementia market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Lewy Body Dementia market growth and SWOT analysis of the Lewy Body Dementia industry, Read More

For detailed insights on the mergers and acquisitions in the Lewy Body Dementia industry,

What are the key dynamics influencing the Lewy Body Dementia market growth? SWOT analysis of the Lewy Body Dementia market. Read More

Global Lewy Body Dementia Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Lewy Body Dementia Global Market Report 2025

Name: Lewy Body Dementia Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Diagnosis (Clinical Diagnosis, Biomarker-Based Diagnosis), By Medication (Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications), By End-User (Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lewy Body Dementia Market Overview

• Lewy Body Dementia market size has reached to $1.12 billion in 2024

• Expected to grow to $1.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%

• Growth Driver: Rising Prevalence Of Brain-Related Disorders Driving The Market Growth

• Market Trend: Research Investments Driving Advancements In Lewy Body Dementia Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lewy Body Dementia Market?

Lewy body dementia (LBD) is a neurodegenerative condition caused by abnormal protein deposits in the brain, impacting cognition, movement, and behavior. This results in a gradual decline in both mental and physical abilities, with symptoms including memory loss, hallucinations, tremors, and motor difficulties. Effective management is essential to address the cognitive and physical challenges associated with the disorder.

The main diagnosis types of lewy body dementia are Clinical Diagnosis and biomarker-based diagnosis. Clinical diagnosis involves identifying diseases like Lewy body dementia based on medical history, symptoms, and physical exams, aiding early recognition and treatment. It is treated with various medications, such as cholinesterase inhibitors, antipsychotics, antidepressants, and others, and used by various end-users, including hospitals, specialty clinics, long-term care facilities, and others.

Lewy Body Dementia Market Size and growth rate 2025 to 2029: Graph

What Is The Lewy Body Dementia Market Size 2025 And Growth Rate?

What Is The Lewy Body Dementia Market Growth Forecast?

The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to $1.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing prevalence of dementia, growing investment in research and development, rising demand for early diagnosis, expanding telemedicine adoption, and focus on personalized medicine. Major trends in the forecast period include development of targeted therapies, expansion of clinical trials, advances in diagnostic techniques, technological advancements, and emphasis on novel therapeutics.

The forecast of 7.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. neurology clinics by increasing costs for specialized PET tracers and cognitive assessment tools sourced from Canada and the Netherlands, potentially delaying accurate dementia diagnoses and raising neurodegenerative disease care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Lewy Body Dementia Market Segmented?

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers

What Is Driving The Lewy Body Dementia Market? Rising Prevalence Of Brain-Related Disorders Driving The Market Growth

The rise in the prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia market going forward. Brain-related disorders refer to a range of conditions affecting the brain’s structure and function, leading to cognitive decline, memory loss, and behavioral changes. The prevalence of brain-related disorders is increasing due to factors such as aging, genetic predisposition, and environmental influences. The increasing prevalence of brain-related disorders boosts the demand for better treatments and early detection for lewy body dementia, which in turn drives research, funding, and innovation, leading to faster advancements in diagnosis and therapy for LBD. For instance, in October 2023, according to the World Federation of Neurology, the UK-based association of national neurological societies, more than 40% of the global population is affected by neurological conditions, with this burden expected to almost double by 2050. Therefore, the rise in the prevalence of brain-related disorders will drive the growth of the lewy body dementia industry.

Who Are The Major Players In The Global Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

What Are The Key Trends Of The Global Lewy Body Dementia Market? Research Investments Driving Advancements In Lewy Body Dementia Treatment

Major companies operating in the lewy body dementia market are focusing on research investment to develop more effective neurodegenerative treatments. Research investment involves dedicating financial resources, time, and effort to scientific and technological studies aimed at uncovering new insights, developing innovative solutions, or enhancing current practices. It supports the exploration of diseases and the creation of new medications, all with the ultimate goal of improving patient outcomes. For instance, in March 2023, the National Institute on Aging, a US-based government agency, awarded $21 million to support drug development research for Lewy Body Dementia (LBD). Researchers at the University of Miami Miller School of Medicine are initiating a Phase 2b study of neflamapimod following encouraging early results.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lewy Body Dementia Market? CND Life Sciences Partnered With Beth Israel Deaconess Medical Center To Enhance Diagnostic Accuracy For Neurodegenerative Disorders

In March 2023, CND Life Sciences, a US-based developer of highly accurate skin-based tests to help clinicians diagnose dementia with Lewy bodies, partnered with Beth Israel Deaconess Medical Center (BIDMC) to enhance its skin-based diagnostic tool for neurodegenerative diseases. This partnership aims to leverage advanced technology to improve the detection of misfolded alpha-synuclein proteins and explore additional protein markers associated with other neurodegenerative disorders, ultimately facilitating more accurate diagnoses and better patient outcomes as new therapies emerge. Beth Israel Deaconess Medical Center (BIDMC) is a US-based company specializing in diagnosing and treating conditions such as Lewy body disease.

What Is The Regional Outlook For The Global Lewy Body Dementia Market?

North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lewy Body Dementia Market?

The lewy body dementia market consists of revenues earned by entities by providing services such as cognitive and motor function therapies, pharmaceutical treatments, and physical therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lewy body dementia market also includes sales of sleep aids, mood stabilizers, and anxiolytics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lewy Body Dementia Industry?

The lewy body dementia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lewy body dementia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Lewy Body Dementia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.2 billion
Revenue Forecast In 2034	$1.58 billion
Growth Rate	CAGR of 7.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The lewy body dementia market covered in this report is segmented – 1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis 2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications 3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users Subsegments: 1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment 2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lewy Body Dementia Market Characteristics

3. Lewy Body Dementia Market Trends And Strategies

4. Lewy Body Dementia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lewy Body Dementia Growth Analysis And Strategic Analysis Framework

5.1. Global Lewy Body Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Lewy Body Dementia Market Growth Rate Analysis

5.4. Global Lewy Body Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Lewy Body Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Lewy Body Dementia Total Addressable Market (TAM)

6. Lewy Body Dementia Market Segmentation

6.1. Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Diagnosis

Biomarker-Based Diagnosis

6.2. Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cholinesterase Inhibitors

Antipsychotics

Antidepressants

Other Medications

6.3. Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Long-Term Care Facilities

Other End-Users

6.4. Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neuropsychological Testing

Neurological Examination

Medical History Review

Cognitive Function Assessment

6.5. Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cerebrospinal Fluid (CSF) Biomarkers

Imaging Biomarkers (PET, MRI)

Genetic Biomarkers

Blood-Based Biomarkers

7. Lewy Body Dementia Market Regional And Country Analysis

7.1. Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lewy Body Dementia Market

8.1. Asia-Pacific Lewy Body Dementia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lewy Body Dementia Market

9.1. China Lewy Body Dementia Market Overview

9.2. China Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lewy Body Dementia Market

10.1. India Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lewy Body Dementia Market

11.1. Japan Lewy Body Dementia Market Overview

11.2. Japan Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lewy Body Dementia Market

12.1. Australia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lewy Body Dementia Market

13.1. Indonesia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lewy Body Dementia Market

14.1. South Korea Lewy Body Dementia Market Overview

14.2. South Korea Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lewy Body Dementia Market

15.1. Western Europe Lewy Body Dementia Market Overview

15.2. Western Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lewy Body Dementia Market

16.1. UK Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lewy Body Dementia Market

17.1. Germany Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lewy Body Dementia Market

18.1. France Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lewy Body Dementia Market

19.1. Italy Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lewy Body Dementia Market

20.1. Spain Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lewy Body Dementia Market

21.1. Eastern Europe Lewy Body Dementia Market Overview

21.2. Eastern Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lewy Body Dementia Market

22.1. Russia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lewy Body Dementia Market

23.1. North America Lewy Body Dementia Market Overview

23.2. North America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lewy Body Dementia Market

24.1. USA Lewy Body Dementia Market Overview

24.2. USA Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lewy Body Dementia Market

25.1. Canada Lewy Body Dementia Market Overview

25.2. Canada Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lewy Body Dementia Market

26.1. South America Lewy Body Dementia Market Overview

26.2. South America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lewy Body Dementia Market

27.1. Brazil Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lewy Body Dementia Market

28.1. Middle East Lewy Body Dementia Market Overview

28.2. Middle East Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lewy Body Dementia Market

29.1. Africa Lewy Body Dementia Market Overview

29.2. Africa Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lewy Body Dementia Market Competitive Landscape And Company Profiles

30.1. Lewy Body Dementia Market Competitive Landscape

30.2. Lewy Body Dementia Market Company Profiles

30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Georgetown University Medical Center Overview, Products and Services, Strategy and Financial Analysis

31. Lewy Body Dementia Market Other Major And Innovative Companies

31.1. Alzheimer's Society

31.2. BioArctic AB

31.3. Annovis Bio Inc.

31.4. Sun Pharma Advanced Research Company Limited

31.5. Voyager Therapeutics Inc.

31.6. Cognition Therapeutics

31.7. Athira Pharma

31.8. Allergan plc

31.9. Inhibikase Therapeutics

31.10. CuraSen Therapeutics Inc.

31.11. CervoMed Inc.

31.12. AC Immune SA

31.13. ProMIS Neurosciences Inc.

31.14. Aptinyx Inc.

31.15. EIP Pharma Inc.

32. Global Lewy Body Dementia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lewy Body Dementia Market

34. Recent Developments In The Lewy Body Dementia Market

35. Lewy Body Dementia Market High Potential Countries, Segments and Strategies

35.1 Lewy Body Dementia Market In 2029 - Countries Offering Most New Opportunities

35.2 Lewy Body Dementia Market In 2029 - Segments Offering Most New Opportunities

35.3 Lewy Body Dementia Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Eli Lilly and Company Financial Performance

Table 77: Mayo Foundation for Medical Education and Research Financial Performance

Table 78: Eisai Co. Ltd. Financial Performance

Table 79: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance

Table 80: Georgetown University Medical Center Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Eli Lilly and Company Financial Performance

Figure 77: Mayo Foundation for Medical Education and Research Financial Performance

Figure 78: Eisai Co. Ltd. Financial Performance

Figure 79: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance

Figure 80: Georgetown University Medical Center Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Alzheimer's Drugs Global Market Report 2025 – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early To Moderate...

Elderly Care Global Market Report 2025 – By Type (Independent Community Living, Assisted Living, Nursing, In-Home Care, Daycare, Hybrid Care, Palliative Care), By Term (Short-Term, Long-Term), By Application (Heart Disea...

Muscle Wasting Disorders Global Market Report 2025 – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, Amyotrophic...

Rare Neurological Disease Treatment Global Market Report 2025 – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Cyberknife, Other Therapies), By Mode Of A...

Smart Pillow Global Market Report 2025 – By Product Type (Anti-Snoring, Multifunctional, Other Products), By Material (Latex Pillow, Foam Pillow, Down and Feather Pillow, Wool Or Cotton Pillow, Polyester Pillow, Other Ma...

Progressive Ataxia And Weakness Disorders Global Market Report 2025 – By Type (Progressive Ataxia, Progressive Weakness Disorders), By Technology (Small Molecule, Monoclonal Antibody, Other Technology), By Distribution C...

Frequently Asked Questions

What is the definition of the Lewy Body Dementia market?

How will the Lewy Body Dementia market drivers and restraints affect the market dynamics? What forces will shape the Lewy Body Dementia industry going forward?

The market major growth driver - Rising Prevalence Of Brain-Related Disorders Driving The Market Growth. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Lewy Body Dementia market?

The lewy body dementia market size has grown strongly in recent years. It will grow from $1.12 billion in 2024 to $1.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to aging population growth, increasing awareness of neurodegenerative diseases, rise in healthcare expenditures, improved diagnostic criteria, and regulatory approvals for dementia drugs. The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to " $1.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing prevalence of dementia, growing investment in research and development, rising demand for early diagnosis, expanding telemedicine adoption, and focus on personalized medicine. Major trends in the forecast period include development of targeted therapies, expansion of clinical trials, advances in diagnostic techniques, technological advancements, and emphasis on novel therapeutics. For further insights on this market, request a sample here

How is the Lewy Body Dementia market segmented?

The lewy body dementiamarket covered in this report is segmented –
1) By Diagnosis: Clinical Diagnosis; Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors; Antipsychotics; Antidepressants; Other Medications
3) By End-User: Hospitals; Specialty Clinics; Long-Term Care Facilities; Other End-Users Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing; Neurological Examination; Medical History Review; Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers; Imaging Biomarkers (PET, MRI); Genetic Biomarkers; Blood-Based Biomarkers For further insights on this market, request a sample here

Which region has the largest share of the Lewy Body Dementia market? What are the other regions covered in the report?

North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Lewy Body Dementia market?

What are the key trends in the Lewy Body Dementia market?

Major trends in this market include Research Investments Driving Advancements In Lewy Body Dementia Treatment. For further insights on this market, request a sample here.